Liquid Biopsy for Precision Oncology Summit West Coast leaderboard
  • Friday, November 20, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

SmartLab Exchange Europe 2027 Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Page 8

As AI and ICH M15 Transform Drug Development, Industry Leaders Convene to Advance Model-Informed…

Oct 20, 2026
FDA, Health Canada, and leading biopharma organizations to explore how artificial intelligence, quantitative modeling, and evolving regulatory expectations are reshaping drug…
Read More...

Estuary Biotherapeutics Launches with $103 Million for Kidney Gene Therapies

Oct 19, 2026
Estuary Biotherapeutics has launched with $103 million in committed financing to develop targeted gene therapies for autosomal dominant polycystic kidney disease (ADPKD), a genetic…
Read More...

Viatris Wins FDA Approval for RYZUMVI to Treat Presbyopia

Oct 19, 2026
Viatris has received approval from the U.S. Food and Drug Administration (FDA) for RYZUMVI (phentolamine ophthalmic solution 0.75%) to treat presbyopia in adults. The approval expands…
Read More...

Roche Wins FDA Approval for Enspryng in Thyroid Eye Disease

Oct 19, 2026
Roche has received approval from the U.S. Food and Drug Administration (FDA) for Enspryng (satralizumab) to treat adults with thyroid eye disease (TED). The approval introduces the…
Read More...

FDA Expands ANKTIVA Approval for Papillary Bladder Cancer

Oct 16, 2026
ImmunityBio has announced that the U.S. Food and Drug Administration (FDA) has expanded the approved use of ANKTIVA (nogapendekin alfa inbakicept-pmln) in combination with Bacillus…
Read More...

Vir Biotechnology and Gilead Partner on Solid Tumor T-Cell Engagers

Oct 16, 2026
Vir Biotechnology has signed a collaboration and licensing agreement with Gilead Sciences to discover and develop three novel T-cell engager (TCE) candidates targeting solid tumors. The…
Read More...

INmune Bio and Quantum Computing Inc. Explore New Uses for Alzheimer’s Drug

Oct 15, 2026
INmune Bio and Quantum Computing Inc. (QCi) have announced a collaboration to use quantum computing, artificial intelligence (AI) and data analytics to identify potential new uses for…
Read More...

Soufflé Therapeutics Raises $135 Million to Advance RNA Therapies

Oct 15, 2026
Soufflé Therapeutics has raised $135 million in an oversubscribed Series B financing round to advance its RNA therapy pipeline and move three lead programmes towards clinical studies.…
Read More...

Alentis and PinotBio Partner to Develop Next-Generation Cancer ADCs

Oct 14, 2026
Alentis Therapeutics and PinotBio have entered into a research collaboration and licensing agreement to develop next-generation antibody-drug conjugates (ADCs) targeting claudin-1, a…
Read More...

Asahi Kasei Wins FDA Approval for HOVILPRI in Resistant Herpes Infections

Oct 14, 2026
Asahi Kasei Therapeutics has received approval from the US Food and Drug Administration (FDA) for HOVILPRI (pritelivir), an oral treatment for difficult-to-treat herpes simplex virus…
Read More...
Previous 1 … 6 7 8 9 10 … 966 Next
Oligonucleotide-based Therapeutics Summit
LEAP HR: Life Sciences Europe
3rd Annual TRP Target Selection & Drug Design Summit
2nd Structure-Based Drug Design Summit San Diego
Liquid Biopsy for Precision Oncology Summit West Coast
2nd Non-Opioid Pain Therapeutics Summit
Muscular Disorders Drug Development Summit
Amylin-Based Therapeutics Summit
Cell Therapy for Autoimmune Disease Summit
Complement-Based Drug Development Summit
World CNS Summit South Korea
Novel CNS Biomarkers Summit Europe
8th CNS Drug Delivery Summit
Antigen-Specific Immune Tolerance Summit
7th Operationalize Expanded Access Programs Summit
Viral Vector Process Development & Manufacturing Summit
SmartLab Exchange Europe 2027
8th RNAi-Based Therapeutics Summit
17th World ADC London
PFS & Injectable Drug Devices Europe
Ophthalmic Drug Delivery Summit
Obesity & Weight Loss Drug Development Summit West
ADC Payload Summit 2026
10th Antifibrotic Drug Development Summit 2026
Biomarker Operations & Biospecimen Management
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • OBI Pharma Signs $2 Billion ADC Deal with Novartis
  • Erasca and Bristol Myers Squibb Partner on Pancreatic Cancer Treatment
  • GSK Wins FDA Approval for Nelkarmi in Advanced Lung Cancer
  • OXB Partners with Aura Biosciences for Phase 3 Cancer Drug Development
  • Skylark Bio Advances Hearing Loss Gene Therapy to Younger Children

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Cell Therapy Safety in Autoimmune Disease

7th Operationalize: Expanded Access Programs Summit East…

As AI and ICH M15 Transform Drug Development, Industry…

Industry Leaders Explore the Future of RNA Therapeutics…

Direct RNA Binding Emerges as a Powerful Approach for…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.